Company / Current Assets per Share
Biogen Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$61.93
FY2025
5-year range
$45.10 / $64.25
FY2021-FY2025
Trend
+19.6%
vs FY2024
Sector context
#7 of 212
Health Care
What the data says
Among 212 Health Care companies, Biogen is in the top 3% for current assets per share. Current Assets per Share has fluctuated over the past 10 years, ranging from $34.92 in FY2020 to $64.25 in FY2022.
Based on SEC 10-K filings.
61.93 in FY2025 with a 5-year CAGR of +12.1%. Top quartile in the Health Care sector.
Improved from $46.66 to $61.93 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -1.2%
- 5-Year CAGR
- +12.1%
- 10-Year CAGR
- -
Sector benchmark
-53.5% below sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 19.6% year-over-year.
- Ranks #7 out of 212 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2022.
- Lowest current assets per share in the period was in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $61.93 | +19.6% |
| FY2024 | $51.78 | +11.0% |
| FY2023 | $46.66 | -27.4% |
| FY2022 | $64.25 | +42.5% |
| FY2021 | $45.10 | +29.1% |
| FY2020 | $34.92 | -11.9% |
| FY2019 | $39.63 | +12.0% |
| FY2018 | $35.39 | -3.0% |
| FY2017 | $36.47 | -8.7% |
| FY2016 | $39.95 | +39.9% |
As of FY2025 · SEC 10-K · Updated Mar 3, 2026